Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway.

Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway.

Galectin-9 is a widely expressed protein that is involved in immune regulation and tumorpathogenesis and serves as a marker of a poor prognosis in various types of cancers. However, the clinical impact and the precise mechanism by which this protein contributes to colon tumor progression are unclear...

Full description

Bibliographic Details
Main Authors: Yang Wang, Jintang Sun, Chao Ma, Wenjuan Gao, Bingfeng Song, Hao Xue, Weiliang Chen, Xi Chen, Yun Zhang, Qianqian Shao, Qingjie Wang, Lei Zhao, Jia Liu, Xiuwen Wang, Huayang Wang, Meixiang Yang, Xun Qu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4814049?pdf=render

Internet

http://europepmc.org/articles/PMC4814049?pdf=render

Similar Items